Casaasdas

Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor

Por um escritor misterioso
Last updated 16 julho 2024
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Construct validity and responsiveness of the simplified version of
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Synthetic Peptide Antibodies as TNF‐α Inhibitors: Molecularly
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Disease control in patients with ankylosing spondylitis in real
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Changes in disease activity after 12 weeks of anti-TNF-α therapy
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Low BASDAI score alone is not a good predictor of anti-tumor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
TNF Inhibitor Therapy, Ankylosing Spondylitis
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Ankylosing spondylitis disease activity score is related to NSAID
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
PDF) ASDAS, BASDAI and different treatment responses and their
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Underweight and obesity are strong predictors of clinical outcomes
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Subanalysis of predictors of clinical remission achievement during
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Effects of ustekinumab on spondylitis-associated endpoints in TNFi
Recomendado para você
você pode gostar

© 2014-2024 radioexcelente.pe. All rights reserved.